Avastin User Fee Date (correction)
This article was originally published in The Pink Sheet Daily
Executive Summary
Genentech's Avastin (bevacizumab) has a user fee date in June under a priority review for patients with previously treated metastatic colorectal cancer. "The Pink Sheet" DAILY had reported an incorrect user fee date for the new indication in a May 23 1article